
Teradyne, Inc.
- What it sells
- Product is 83% of revenue (fiscal year to Dec 2025), up from 78% two years earlier.
- Growing?
- Yes: revenue up 70% on a year earlier (quarter ended Sep 2026); earnings per share up 217% over the last four quarters.
- Expensive?
- About usual: 30.3× trailing earnings; its five-year median is 31.5×. Priced 23% below the peer median of 39.4x.
- Analysts?
- 76% of 17 say buy; average 12-month target $425, 61% above today's price.
- Risky?
- Much swingier than most large companies: its price swung 79% over the past year (the S&P 500's 14%), and it fell as much as 60% since Nov 2021.
Teradyne, Inc. designs and manufactures automated test equipment (ATE) and related software/services used to test semiconductors and complex electronic systems, and it also sells advanced robotics solutions (including collaborative robots and autonomous mobile robots).
More about Teradyne
Revenue is primarily generated from system sales (test platforms/robots) plus recurring streams from services, support, and consumables/spares.
Market Position
Teradyne is a leading supplier in semiconductor test and competes on test accuracy, throughput, reliability, and total cost of test across high-volume production environments. In robotics/automation, it competes in collaborative and mobile robotics with differentiation around a portfolio platform approach (cobots, AMRs, and control software) and established industrial distribution.
Key Segments
Teradyne reports four segments: Semiconductor Test, System Test, Wireless Test, and Robotics.
How has the stock done?
Over the past month TER fell 31.3%; the semiconductor ETF (SMH) fell 15.1% and the S&P 500 fell 2.7%.
Over the past six months TER fell 26.4%; the semiconductor ETF (SMH) fell 10.6% and the S&P 500 rose 2.6%.
Over the past year TER rose 47.1%; the semiconductor ETF (SMH) rose 41.1% and the S&P 500 rose 10.8%.
Over five years TER rose 80.4%; the semiconductor ETF (SMH) rose 233.3% and the S&P 500 rose 62.0%.
From Dec 27, 2021 to Apr 8, 2025, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 3.4% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 28, 2026 | ended Sep 2026 | $1.3B (+70% vs a year earlier) | $2.29 vs $2.06 (beat) | −8.5% | −22.5% |
| Jul 29, 2026 | ended Jun 2026 | $1.3B (+104% vs a year earlier) | $2.47 vs $2.05 (beat) | +14.0% | +21.4% |
| Apr 29, 2026 | ended Mar 2026 | $1.3B (+87% vs a year earlier) | $2.56 vs $2.12 (beat) | −9.6% | +0.6% |
| Feb 3, 2026 | ended Dec 2025 | $1.1B (+44% vs a year earlier) | $1.80 vs $1.38 (beat) | +7.8% | +22.2% |
| Oct 29, 2025 | ended Sep 2025 | $769M (+4% vs a year earlier) | — | +22.5% | +29.9% |
| Jul 30, 2025 | ended Jun 2025 | $652M (−11% vs a year earlier) | — | +18.6% | +15.8% |
| Apr 29, 2025 | ended Mar 2025 | $686M (+14% vs a year earlier) | — | −3.4% | −3.6% |
| Jan 30, 2025 | ended Dec 2024 | $753M (+12% vs a year earlier) | — | −5.1% | −6.5% |
| Oct 24, 2024 | ended Sep 2024 | $737M (+5% vs a year earlier) | — | −10.2% | −14.6% |
| Jul 25, 2024 | ended Jun 2024 | $730M (+7% vs a year earlier) | — | −11.9% | −15.2% |
| Apr 25, 2024 | ended Mar 2024 | $600M (−3% vs a year earlier) | — | +13.3% | +16.6% |
| Jan 31, 2024 | ended Dec 2023 | $671M (−8% vs a year earlier) | — | −9.0% | −6.8% |
| Oct 26, 2023 | ended Sep 2023 | $704M (−15% vs a year earlier) | — | −4.6% | −2.3% |
| Jul 27, 2023 | ended Jun 2023 | $684M (−19% vs a year earlier) | — | −2.0% | −6.2% |
| Apr 27, 2023 | ended Mar 2023 | $618M (−18% vs a year earlier) | — | −2.1% | −3.6% |
| Jan 26, 2023 | ended Dec 2022 | $732M (−17% vs a year earlier) | — | 0.0% | +7.8% |
| Oct 26, 2022 | ended Sep 2022 | $827M (−13% vs a year earlier) | — | +0.3% | −0.3% |
| Jul 27, 2022 | ended Jun 2022 | $841M (−23% vs a year earlier) | — | +0.8% | +3.3% |
| Apr 27, 2022 | ended Mar 2022 | $755M (−3% vs a year earlier) | — | +3.7% | +6.0% |
| Jan 27, 2022 | ended Dec 2021 | $885M (+17% vs a year earlier) | — | −21.8% | −22.0% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $1.3B in the quarter ended Sep 2026, up 70% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $732M | −17% |
| Mar 2023 | $618M | −18% |
| Jun 2023 | $684M | −19% |
| Sep 2023 | $704M | −15% |
| Dec 2023 | $671M | −8% |
| Mar 2024 | $600M | −3% |
| Jun 2024 | $730M | +7% |
| Sep 2024 | $737M | +5% |
| Dec 2024 | $753M | +12% |
| Mar 2025 | $686M | +14% |
| Jun 2025 | $652M | −11% |
| Sep 2025 | $769M | +4% |
| Dec 2025 | $1.1B | +44% |
| Mar 2026 | $1.3B | +87% |
| Jun 2026 | $1.3B | +104% |
| Sep 2026 | $1.3B | +70% |
Revenue went from $3.2B in FY22 to $3.2B in FY25; net income from $716M to $554M.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $3.2B | $716M |
| FY23 | $2.7B | $449M |
| FY24 | $2.8B | $542M |
| FY25 | $3.2B | $554M |
In the fiscal year to Dec 2025, Product was 83% and Service was 17% of revenue; Product rose from 78% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Product | $2.1B | 78% |
| FY2023 | Service | $580M | 22% |
| FY2024 | Product | $2.3B | 81% |
| FY2024 | Service | $525M | 19% |
| FY2025 | Product | $2.7B | 83% |
| FY2025 | Service | $530M | 17% |
In the fiscal year to Dec 2025, Taiwan was 36% and South Korea was 14% of revenue; Taiwan rose from 14% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | United States | $434M | 16% |
| FY2023 | South Korea | $395M | 15% |
| FY2023 | Taiwan | $385M | 14% |
| FY2023 | Other | $1.5B | 55% |
| FY2024 | Taiwan | $602M | 21% |
| FY2024 | Americas | $435M | 15% |
| FY2024 | United States | $374M | 13% |
| FY2024 | Other | $1.4B | 50% |
| FY2025 | Taiwan | $1.2B | 36% |
| FY2025 | South Korea | $446M | 14% |
| FY2025 | Americas | $426M | 13% |
| FY2025 | United States | $361M | 11% |
| FY2025 | Europe | $215M | 7% |
| FY2025 | Other | $587M | 18% |
A year earlier $0.75
Diluted, from SEC filings
Quarters: Teradyne, Inc.'s SEC filings, named by the month they end. Fiscal years: Teradyne, Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $17.4 ends up as net income. Net margin fell from 22.7% to 17.4% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 57.5% | 22.8% | 23.5% |
| Mar 2023 | 57.7% | 15.0% | 13.5% |
| Jun 2023 | 58.8% | 20.4% | 17.5% |
| Sep 2023 | 56.6% | 20.5% | 18.2% |
| Dec 2023 | 56.6% | 18.5% | 17.5% |
| Mar 2024 | 56.6% | 13.0% | 10.7% |
| Jun 2024 | 58.3% | 28.8% | 25.5% |
| Sep 2024 | 59.2% | 20.6% | 19.8% |
| Dec 2024 | 59.4% | 20.4% | 19.4% |
| Mar 2025 | 60.6% | 17.6% | 14.4% |
| Jun 2025 | 57.2% | 13.9% | 12.0% |
| Sep 2025 | 58.4% | 18.9% | 15.5% |
| Dec 2025 | 57.2% | 27.1% | 23.7% |
| Mar 2026 | 60.9% | 36.9% | 31.1% |
| Jun 2026 | 59.8% | 32.9% | 28.2% |
| Sep 2026 | 59.1% | 30.8% | 26.2% |
−1.0 pts over 3 years
−6.0 pts over 3 years
−5.3 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Teradyne, Inc.'s annual reports to the SEC; quarters: SEC filings.
Where it is in the chip cycle
Gross margin 59.8%, down 1.1 points on the quarter but up 2.6 points from a year earlier; inventory at 104 days, up from 93 a year earlier; capital spending 5.9% of revenue over the last 4 quarters.
Show the data
| Period | Inventory days |
|---|---|
| FY22 | 92 |
| FY23 | 99 |
| FY24 | 93 |
| FY25 | 104 |
How many days of sales are sitting in stock. Rising inventory days often come before a downturn: chips are being made faster than they sell.
Show the data
| Period | Capital spending |
|---|---|
| Jun ’25 | 7.7% |
| Sep ’25 | 6.1% |
| Dec ’25 | 5.8% |
| Mar ’26 | 5.0% |
| Jun ’26 | 6.8% |
Money put into factories and equipment. Heavy spending late in an upswing can leave the industry with too much capacity when demand cools.
Gross margin by fiscal quarter, from SEC filings. Inventory days: year-end inventory over that year's cost of revenue, times 365.
Customers and suppliers
In its latest annual report Teradyne buys from Flex, Plexus, SAM Meerkat; sells to Infineon Technologies; three customers it does not name account for 12% and 10% and 19% of its revenue.
Suppliers
Customers
Partners
Changes since the previous annual report (10-K filed Feb 20, 2025)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| MultiLane | partner · joint venture with it | “On January 29, 2026, we and MultiLane, a leading high-speed input/output (“I/O”) test and measurement company, announced an agreement to form a joint venture, MultiLane Test Products (“MLTP”).” |
| Infineon Technologies | customer | “On January 31, 2025, we acquired Infineon Technologies AG's (“Infineon”) automated test equipment technology and associated development team (“AET”) based in Regensburg, Germany for a total purchase price of 17.6 million Euros, equivalent to $18.3 million. AET adds resources and expertise to our company and strengthens the relationship between us and this key customer.” |
| Largest specifying customer (unnamed) | customer | “In 2025, we had two customers who specified greater than 10% of our consolidated revenues and one additional customer who directly purchased more than 10% of our consolidated revenues. The two specifying customers were both customers of our Semiconductor Test and Product Test segments and drove 12% and 10% of consolidated revenues.” |
| Second largest specifying customer (unnamed) | customer | “In 2025, we had two customers who specified greater than 10% of our consolidated revenues and one additional customer who directly purchased more than 10% of our consolidated revenues. The two specifying customers were both customers of our Semiconductor Test and Product Test segments and drove 12% and 10% of consolidated revenues.” |
| The additional direct customer (unnamed) | customer | “In 2025, we had two customers who specified greater than 10% of our consolidated revenues and one additional customer who directly purchased more than 10% of our consolidated revenues....The additional direct customer, a customer of our Semiconductor Test segment, accounted for 19% of consolidated revenues including certain revenues specified by other customers.” |
| Technoprobe | partner · Teradyne invested in it | “On May 27, 2024, Teradyne paid 483.1 million Euros, equivalent to $524.1 million, to purchase a combination of previously issued and outstanding shares and shares newly issued by Technoprobe, S.p.A. (“Technoprobe”). The shares purchased represent 10% of the issued and outstanding shares of Technoprobe.” |
| Flex | supplier | “We depend on Flex Ltd. (“Flex”) to manufacture and test our FLEX and J750 family of products from its facility in Malaysia; Plexus Corp. (“Plexus”) to manufacture and test our FLEX and Magnum products from its facilities in Malaysia and Thailand and our ETS family of products from its facility in Malaysia; SAM Meerkat to manufacture and test our storage test family of products from its facilities in Malaysia and Thailand and on other contract manufacturers to manufacture other products.” |
| Plexus | supplier | “We depend on Flex Ltd. (“Flex”) to manufacture and test our FLEX and J750 family of products from its facility in Malaysia; Plexus Corp. (“Plexus”) to manufacture and test our FLEX and Magnum products from its facilities in Malaysia and Thailand and our ETS family of products from its facility in Malaysia; SAM Meerkat to manufacture and test our storage test family of products from its facilities in Malaysia and Thailand and on other contract manufacturers to manufacture other products.” |
| SAM Meerkat | supplier | “We depend on Flex Ltd. (“Flex”) to manufacture and test our FLEX and J750 family of products from its facility in Malaysia; Plexus Corp. (“Plexus”) to manufacture and test our FLEX and Magnum products from its facilities in Malaysia and Thailand and our ETS family of products from its facility in Malaysia; SAM Meerkat to manufacture and test our storage test family of products from its facilities in Malaysia and Thailand and on other contract manufacturers to manufacture other products.” |
| ASE Technology (20-F filed Apr 1, 2026) | calls it a supplier | “We purchase testers from major international manufacturers, primarily Teradyne, Inc., Tokyo Electron Limited, and Advantest Corporation.” |
Only the companies Teradyne names in its 10-K filed Feb 19, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words. Customers it does not name are listed as the filing describes them.
Is it expensive?
P/E of 30.3x, below the peer median of 39.4x, with earnings still growing.
Priced 23% below the peer median of 39.4x.
Show the data
| Company | P/E (trailing) |
|---|---|
| ENTG · Entegris, Inc. | 59.6× |
| Q · Qnity Electronics, Inc. | 46.1× |
| KLAC · KLA Corporation | 39.4× |
| LRCX · Lam Research Corporation | 34.8× |
| AMAT · Applied Materials, Inc. | 32.9× |
| TER · Teradyne, Inc. | 30.3× |
At 30.3× trailing earnings TER is inside the middle of its five-year range; the five-year median is 31.5×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 27.1× |
| Feb 8, 2022 | 21.0× |
| May 10, 2022 | 19.1× |
| Aug 10, 2022 | 20.8× |
| Nov 8, 2022 | 19.4× |
| Feb 9, 2023 | 25.5× |
| May 11, 2023 | 23.9× |
| Aug 11, 2023 | 30.1× |
| Nov 9, 2023 | 27.8× |
| Feb 12, 2024 | 37.7× |
| May 13, 2024 | 47.5× |
| Aug 13, 2024 | 41.8× |
| Nov 11, 2024 | 34.5× |
| Feb 13, 2025 | 33.9× |
| May 15, 2025 | 23.4× |
| Aug 15, 2025 | 37.9× |
| Nov 13, 2025 | 61.7× |
| Feb 17, 2026 | 87.8× |
| May 18, 2026 | 59.5× |
| Aug 18, 2026 | 55.5× |
| Nov 12, 2026 | 30.3× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $425, 61% above the current price; 76% of 17 analysts rate it a buy; earnings beat estimates in all of the last 4 quarters.
Buy or Strong Buy: 13 analysts (76%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $169.89 to $469.62 (+176%), while TER went from $169.59 to $263.75 (+56%). In the past three months targets were cut once and never raised. 3 upgrades and 1 downgrade over the year; the latest: Baird moved it to Neutral from Outperform on Aug 21, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Oct 29, 2026 | UBS | Target cut | Buy | $430.00, was $485.00 |
| Aug 21, 2026 | Baird | Downgrade | Neutral, was Outperform | $420.00 |
| Jul 30, 2026 | Morgan Stanley | Target raised | Equal-Weight | $397.00, was $387.00 |
| Jul 30, 2026 | Evercore ISI Group | Target raised | Outperform | $420.00, was $370.00 |
| Jul 29, 2026 | Cantor Fitzgerald | Target kept | Overweight | $550.00 |
| Jul 20, 2026 | UBS | Target raised | Buy | $500.00, was $440.00 |
| Jul 6, 2026 | Goldman Sachs | Target raised | Buy | $465.00, was $350.00 |
| Jun 30, 2026 | Susquehanna | Target raised | Positive | $550.00, was $415.00 |
| Jun 29, 2026 | Cantor Fitzgerald | Target raised | Overweight | $550.00, was $400.00 |
| Jun 23, 2026 | B of A Securities | Target raised | Buy | $525.00, was $365.00 |
| Jun 23, 2026 | Baird | Target raised | Outperform | $446.00, was $350.00 |
| Apr 30, 2026 | JP Morgan | Upgrade | Overweight, was Neutral | $400.00 |
| Apr 30, 2026 | Citigroup | Target raised | Buy | $400.00, was $325.00 |
| Apr 30, 2026 | Goldman Sachs | Target raised | Buy | $350.00, was $300.00 |
| Apr 30, 2026 | Evercore ISI Group | Target cut | Outperform | $370.00, was $430.00 |
| Apr 28, 2026 | Stifel | Target raised | Buy | $390.00, was $325.00 |
| Apr 28, 2026 | Evercore ISI Group | Target raised | Outperform | $430.00, was $320.00 |
| Apr 21, 2026 | UBS | Target raised | Buy | $440.00, was $325.00 |
| Apr 16, 2026 | JP Morgan | Target raised | Neutral | $400.00, was $315.00 |
| Apr 9, 2026 | Susquehanna | Target raised | Positive | $415.00, was $335.00 |
| Apr 9, 2026 | Cantor Fitzgerald | Target raised | Overweight | $400.00, was $330.00 |
| Mar 30, 2026 | Baird | Target raised | Outperform | $332.00, was $305.00 |
| Feb 4, 2026 | Goldman Sachs | Target raised | Buy | $300.00, was $230.00 |
| Feb 4, 2026 | Citigroup | Target raised | Buy | $325.00, was $215.00 |
| Feb 4, 2026 | Cantor Fitzgerald | Target raised | Overweight | $330.00, was $270.00 |
| Feb 4, 2026 | Evercore ISI Group | Target raised | Outperform | $320.00, was $280.00 |
| Feb 4, 2026 | Stifel | Target raised | Buy | $325.00, was $280.00 |
| Feb 3, 2026 | Evercore ISI Group | Target raised | Outperform | $280.00, was $200.00 |
| Feb 2, 2026 | Cantor Fitzgerald | Target raised | Overweight | $270.00, was $240.00 |
| Jan 30, 2026 | Stifel | Target raised | Buy | $280.00, was $270.00 |
| Jan 26, 2026 | UBS | Target raised | Buy | $275.00, was $200.00 |
| Jan 22, 2026 | B of A Securities | Target raised | Buy | $260.00, was $250.00 |
| Jan 14, 2026 | Stifel | Target raised | Buy | $270.00, was $225.00 |
| Jan 13, 2026 | B of A Securities | Target raised | Buy | $250.00, was $235.00 |
| Dec 16, 2025 | Goldman Sachs | Upgrade | Buy, was Sell | $230.00, was $148.00 |
| Dec 2, 2025 | Stifel | Upgrade | Buy, was Hold | $225.00, was $162.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $1.38 | $1.80 | +30.4% |
| Mar ’26 | $2.12 | $2.56 | +20.8% |
| Jun ’26 | $2.05 | $2.47 | +20.5% |
| Sep ’26 | $2.06 | $2.29 | +11.2% |
The day after each of these reports the stock moved +7.8% (Dec 2025, beat); −9.6% (Mar 2026, beat); +14.0% (Jun 2026, beat); −8.5% (Sep 2026, beat).
For the quarter ending Dec 2026 (Teradyne reports on Jan 27, 2027), analysts expect adjusted earnings of $2.12 a share, 18% more than the $1.80 of a year earlier, and revenue of $1.3B, up 21% on a year earlier. For the fiscal year ending Dec 2027, they expect adjusted earnings of $11.99 a share, 27% more than the year before's estimate of $9.44, and revenue of $6.5B, up 25% on the year before's estimate.
Adjusted. Dec 2025: $1.80; range $2.08 to $2.24; 14 analysts
Dec 2025: $1.1B; range $1.3B to $1.4B; 14 analysts
Adjusted. The year to Dec 2026: $9.44 expected; range $9.00 to $13.84; 17 analysts
The year to Dec 2026: $5.2B expected; range $5.8B to $7.1B; 17 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 27, 2027 | EPS (adjusted) | $2.12 | $2.08 to $2.24 | 14 | $1.80 (Dec 2025) | +18% |
| Quarter ending Dec 2026, results Jan 27, 2027 | Revenue | $1.3B | $1.3B to $1.4B | 14 | $1.1B (Dec 2025) | +21% |
| Quarter ending Mar 2027 | EPS (adjusted) | $2.35 | $2.08 to $2.74 | 13 | $2.56 (Mar 2026) | −8% |
| Quarter ending Mar 2027 | Revenue | $1.4B | $1.3B to $1.6B | 12 | $1.3B (Mar 2026) | +9% |
| Year ending Dec 2026 | EPS (adjusted) | $9.44 | $9.40 to $9.55 | 15 | — | — |
| Year ending Dec 2026 | Revenue | $5.2B | $5.2B to $5.3B | 16 | $3.2B (year to Dec 2025) | +64% |
| Year ending Dec 2027 | EPS (adjusted) | $11.99 | $9.00 to $13.84 | 17 | $9.44 (expected, year to Dec 2026) | +27% |
| Year ending Dec 2027 | Revenue | $6.5B | $5.8B to $7.1B | 17 | $5.2B (expected, year to Dec 2026) | +25% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $1.0B in free cash flow over the year, of which $430M went back to shareholders (dividends plus buybacks), leaving $590M in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $1.3B |
| Capex | −$310M |
| Free cash flow | $1.0B |
| Dividends | −$80M |
| Buybacks | −$350M |
| Cash retained | $590M |
For every $100 of market cap, the company generates about $2.5 in free cash flow a year.
For every $100 of market cap, you receive about $0.2 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $1.1 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $204M | $17M | $51M |
| Mar 2024 | −$37M | $18M | $22M |
| Jun 2024 | $171M | $19M | $8.2M |
| Sep 2024 | $114M | $20M | $25M |
| Dec 2024 | $225M | $19M | $144M |
| Mar 2025 | $98M | $19M | $157M |
| Jun 2025 | $132M | $19M | $117M |
| Sep 2025 | $2.4M | $19M | $244M |
| Dec 2025 | $219M | $19M | $183M |
| Mar 2026 | $200M | $20M | $5.5M |
| Jun 2026 | $378M | $20M | $69M |
| Sep 2026 | $227M | $20M | $99M |
Teradyne had 158M diluted shares in the quarter ended Sep 2026, 1.0% fewer than a year earlier, and 2.1% fewer each year on average since Mar 2020. It spent $357M on buybacks over the last four quarters. Over the last four quarters its earnings per share rose 216.7% and its net income rose 209.9%: fewer shares added about 7 points.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Mar 2020 | 181M |
| Jun 2020 | 180M |
| Sep 2020 | 184M |
| Mar 2021 | 188M |
| Jun 2021 | 187M |
| Sep 2021 | 182M |
| Mar 2022 | 176M |
| Jun 2022 | 171M |
| Mar 2023 | 166M |
| Jun 2023 | 165M |
| Sep 2023 | 164M |
| Mar 2024 | 162M |
| Jun 2024 | 163M |
| Sep 2024 | 164M |
| Mar 2025 | 162M |
| Jun 2025 | 160M |
| Sep 2025 | 159M |
| Mar 2026 | 158M |
| Jun 2026 | 158M |
| Sep 2026 | 158M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 1.7, no pressure to repay short-term debt; debt-to-equity 0.1, debt is very low and the balance sheet is solid.
Assets that can be turned into cash soon are 1.7x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.1 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $322M against debt of $200M. Lease obligations of $83M are not counted: they are rent owed, not money borrowed. It also holds $663M of long-term investments, $126M of them securities it could sell.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 10 funds whose copy leaves TER out (on the exchange, not in the app yet): Tensor Edge Capital, Mirae Asset Global Investments, Bridgewater Associates, Norges Bank, Swiss National Bank, Temasek Holdings (Private) and 4 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 16 held TER at the end of their latest quarter (for most, Q2 2026). Over that quarter 8 added shares, 6 cut, 2 bought new and 1 sold all. The largest of them is Norges Bank, 2.22M shares worth $1.1B at Jun 30, 2026, 7.9% more than at Dec 31, 2025.
2 of them new holders
1 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 2.22M | $1.1B | +163,643 | +7.9% | Aug 12, 2026 |
| Lone Pine Capital | Q2 2026 | 1.49M | $722M | −379,796 | −20% | Aug 14, 2026 |
| ARK Investment Management | Q2 2026 | 644,782 | $312M | −600,340 | −48% | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 428,160 | $172M | −13,440 | −3.0% | Nov 12, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 367,810 | $147M | +19,567 | +5.6% | Nov 3, 2026 |
| National Pension Service | Q3 2026 | 283,973 | $114M | +1,638 | +0.6% | Nov 12, 2026 |
| Renaissance Technologies | Q3 2026 | 232,140 | $93.1M | +14,040 | +6.4% | Nov 12, 2026 |
| Nomura Holdings | Q2 2026 | 186,833 | $90.4M | +185,104 | +10706% | Aug 14, 2026 |
| Tensor Edge Capital | Q3 2026 | 187,925 | $75.3M | +9,747 | +5.5% | Nov 6, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 0 | — | −207,134 | Sold all | Aug 14, 2026 |
| Korea Investment | Q2 2026 | 125,732 | $60.8M | −173,851 | −58% | Aug 12, 2026 |
| Bridgewater Associates | Q2 2026 | 98,627 | $47.7M | −240,319 | −71% | Aug 14, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 67,039 | $32.4M | +12,220 | +22% | Aug 14, 2026 |
| Temasek Holdings (Private) | Q3 2026 | 77,032 | $30.9M | −4,214 | −5.2% | Oct 28, 2026 |
| Maverick Capital | Q2 2026 | 2,101 | $1.0M | +2,101 | New | Aug 14, 2026 |
| Fisher Asset Management | Q3 2026 | 738 | $296K | +738 | New | Nov 6, 2026 |
| Baillie Gifford & | Q3 2026 | 266 | $107K | +65 | +32% | Nov 9, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of TER at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors sold $15.7M of TER on the open market in the 12 months to Nov 12, 2026; none bought. 100% of the sales were made under 10b5-1 plans, set up in advance. The largest was Gregory Stephen Smith (President and CEO; director), who sold $10.7M in 7 sales.
32 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 166 | $275.44 | $46K | Nov 3, 2026 |
| Oct 21, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 400 | $350.00 | $140K | Oct 22, 2026 |
| Oct 15, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 800 | $341.28 | $273K | Oct 19, 2026 |
| Oct 15, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 4,000 | $341.28 | $1.4M | Oct 19, 2026 |
| Oct 1, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 167 | $402.90 | $67K | Oct 2, 2026 |
| Sep 17, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 400 | $351.11 | $140K | Sep 18, 2026 |
| Sep 15, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 800 | $337.83 | $270K | Sep 16, 2026 |
| Sep 15, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 4,000 | $337.83 | $1.4M | Sep 16, 2026 |
| Sep 1, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 167 | $341.30 | $57K | Sep 2, 2026 |
| Aug 17, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 1,200 | $425.00 | $510K | Aug 18, 2026 |
| Aug 17, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 4,000 | $425.00 | $1.7M | Aug 18, 2026 |
| Aug 3, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 166 | $358.15 | $59K | Aug 4, 2026 |
| Jul 15, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 1,200 | $356.31 | $428K | Jul 16, 2026 |
| Jul 15, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 4,000 | $356.31 | $1.4M | Jul 16, 2026 |
| Jul 1, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 167 | $460.00 | $77K | Jul 2, 2026 |
| Jun 15, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 4,000 | $423.03 | $1.7M | Jun 16, 2026 |
| Jun 15, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 1,200 | $423.03 | $508K | Jun 16, 2026 |
| Jun 2, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 167 | $369.74 | $62K | Jun 3, 2026 |
| May 22, 2026 | Shannon John Poulin | President, Semiconductor Test | Sale (10b5-1 plan) | 656 | $355.00 | $233K | May 26, 2026 |
| May 21, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 400 | $350.00 | $140K | May 26, 2026 |
| May 21, 2026 | Shannon John Poulin | President, Semiconductor Test | Sale (10b5-1 plan) | 1,008 | $345.37 | $348K | May 26, 2026 |
| May 15, 2026 | Marilyn Matz | Director | Sale (10b5-1 plan) | 800 | $338.98 | $271K | May 19, 2026 |
| May 15, 2026 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 8,597 | $338.98 | $2.9M | May 19, 2026 |
| May 7, 2026 | Ryan Driscoll | VP, General Counsel, Secretary | Sale (10b5-1 plan) | 680 | $377.60 | $257K | May 11, 2026 |
| Apr 6, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 625 | $312.20 | $195K | Apr 7, 2026 |
| Apr 2, 2026 | Regan Mills | President, Product Test | Sale (10b5-1 plan) | 252 | $290.88 | $73K | Apr 3, 2026 |
| Mar 5, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 625 | $299.20 | $187K | Mar 6, 2026 |
| Feb 25, 2026 | Regan Mills | President, Product Test | Sale (10b5-1 plan) | 788 | $332.87 | $262K | Feb 27, 2026 |
| Feb 5, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 625 | $266.98 | $167K | Feb 6, 2026 |
| Jan 5, 2026 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 625 | $211.85 | $132K | Jan 6, 2026 |
| Dec 12, 2025 | Gregory Stephen Smith | President and CEO; director | Sale (10b5-1 plan) | 1,108 | $201.31 | $223K | Dec 15, 2025 |
| Dec 5, 2025 | Mercedes Johnson | Director | Sale (10b5-1 plan) | 625 | $200.00 | $125K | Dec 8, 2025 |
From the Form 4s filed with the SEC about Teradyne, Inc. (75 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 56 other transactions (grants, option exercises, shares withheld for tax, shares sold to pay tax and other transfers).